Table 1.

Clinical characteristics and outcomes (n=43).

Characteristics	Values
Age, mean years (SD)	37.4 (11.0)
Gender, male n (%)	24 (56)
CD4 count, mean (SD)   >200 n (%)   <50 n (%)   50-200 n (%)	186 (215) 14 (33) 12 (28) 17 (40)
WHO clinical stage, n=40, n (%)	I: 6 (14) II: 2 (5) III: 14 (36) IV: 18 (43)
Antiretroviral use, n (%)	Never: 24 (56) Active: 16 (37) Defaulted: 3 (7)
Psychiatric Symptom Burden n=59 mean Shona Symptom Score (SD)	4.6 (3.0): 56% requiring additional evaluation*
International HIV Dementia Scale, n=59 (mean, SD, % impaired)	8.7 (2.8): 54% impaired
Zambian Mini-Mental State Exam n=59 (mean, SD, % impaired)	20.7 (3.9): 51% impaired
Seizure severity at first seizure, n (%)	Single, brief seizure 15 (35); Multiple seizures, not status epilepticus 20 (47); Status epilepticus 8 (19)
CNS opportunistic infection n=31, n (%)	14 (44)
Outcomes, n (%)	Recurrent seizures 15 (35) Died 9 (21)

*Based upon score and recommendations during Zimbabwe-based validation studies.